MetLife Investment Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1529735
Whippany, NJ
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,887,256
-$6,635,367 QoQ
Shares Held
284,053
-6.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#257
of 2,284 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $750,511,239 across 12 Drug Manufacturers - General names. GILD ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
212,458 | $254,828,520 | |
| 2 | JNJ |
Johnson & Johnson
|
550,760 | $139,876,517 | |
| 3 | ABBV |
AbbVie Inc.
|
409,814 | $103,125,594 | |
| 4 | MRK |
Merck & Co., Inc.
|
565,110 | $72,616,635 | |
| 5 | AMGN |
Amgen Inc
|
138,472 | $50,143,480 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
284,053 | $35,887,256 | |
| 7 | PFE |
Pfizer Inc
|
1,303,824 | $31,396,081 | |
| 8 | AZN |
Astrazeneca PLC
|
149,538 | $28,355,395 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,887,256 | 284,053 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $42,522,623 | 305,106 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $38,498,996 | 313,663 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $35,943,687 | 323,817 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $36,835,892 | 332,244 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $36,274,058 | 323,731 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $30,472,678 | 329,898 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,146,469 | 323,789 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,802,533 | 332,350 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $21,376,401 | 291,828 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $24,510,790 | 302,565 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $23,102,428 | 308,279 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $24,404,600 | 316,655 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $26,716,174 | 321,998 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $28,124,030 | 327,595 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $20,526,792 | 332,741 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $20,888,009 | 337,939 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $20,292,722 | 341,341 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $20,123,571 | 277,146 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $19,780,542 | 283,186 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $20,022,766 | 290,775 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $19,353,130 | 299,445 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $17,735,858 | 304,426 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $20,086,394 | 317,873 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $25,233,780 | 327,967 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $24,379,759 | 326,107 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||